Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Screening and Treatment of Depression in the Community [Phase 4]
Phase 4 clinical trial completed evaluating screening and treatment for depression in community settings, sponsored by National University H…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Comparison of Two Psychotherapy Treatments for Depressed Women With a History of Sexual Abuse [Phase 1, Phase 2]
The study compared two psychotherapy treatments for depressed women with a history of sexual abuse across Phase 1 and Phase 2; results from …
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: Serum Markers as a Bioassay for Unipolar Depression
This completed clinical trial evaluated serum markers as a bioassay for major depressive disorder; the snippet does not report results.
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product manufactured by NorthStar Rx LLC.
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals, confirming the continued author…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Modulation of Cognitive Control by Transcranial Direct Current Stimulation [NA]
This clinical trial explored whether transcranial direct current stimulation can modulate cognitive control in adults with major depressive …
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Exercise and Severe Depression: Clinical and Biological Analysis [NA]
A completed clinical trial investigating the effects of exercise on severe depression, including clinical and biological analyses.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers [NA]
A completed clinical trial evaluating the impact of structured exercise on depression symptoms. The study used neurotransmitter levels and E…
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder [Phase 4]
Phase 4 clinical trial update for outpatients with severe asthma and moderate or severe major depressive disorder; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-12-27Clinical Trial Update: Mental Health First Aid for College Students [NA]
A completed clinical trial evaluating a mental health first aid program for college students, addressing depression, anxiety, suicidal ideat…
-
FDA approval · 2013-12-23FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Wellbutrin SR (bupropion hydrochloride) by GlaxoSmithKline LLC.
-
FDA approval · 2013-12-23FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) submitted by Wyeth/Pfizer.
-
FDA approval · 2013-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Venlafaxine Hydrochloride by Aurobindo Pharma Limited, updating the regulatory status of thi…
-
FDA approval · 2013-12-19FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC (NDA 204516).
-
FDA approval · 2013-12-19FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC under ANDA202227, enabling continued co…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
A retrospective analysis evaluating the outcomes of combining Deplin (L-methylfolate) with antidepressant therapy for Major Depressive Disor…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder
A descriptive follow-up study on bipolar disorder conducted by Peking University; the current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy and safety of vortioxetine for major depressive disorder; results were posted in 2013 following comp…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating 5 mg vortioxetine (Lu AA21004) for the acute treatment of major depressive disorder …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder [Phase 3]
This Phase 3 clinical trial update reports efficacy and safety results for vortioxetine in adults with major depressive disorder, with resul…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
Phase 3 efficacy and safety study of vortioxetine in adults with major depressive disorder completed, with results posted in December 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
A Phase 3 safety and efficacy study of vortioxetine in adults with major depressive disorder has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
This document reports the completion and results posting of a Phase 3 efficacy trial of vortioxetine in adults with major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial results evaluate the safety and efficacy of vortioxetine (Lu AA21004) in adults with major depressive disorder. The s…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram [Phase 1]
Phase 1 pharmacodynamics and pharmacokinetics data for the antidepressants citalopram and escitalopram were reported.